Tokyo Tape
Sign in
← Solasia Pharma

Quarterly report · Q3

4597.TEDINET S100PMXV
Period2022-01-01 → 2022-09-30
Filed2022-11-14
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥485m2022-01-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥295m2022-07-01 → 2022-09-30dCons.Revenue IFRS
Revenue¥559m2021-01-01 → 2021-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥283m2021-01-01 → 2021-09-30Cons.Revenue IFRS
Revenue¥5m2021-07-01 → 2021-09-30dCons.Revenue IFRS
Operating income−¥2.0bn2022-01-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income−¥723m2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income−¥2.1bn2021-01-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income−¥701m2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax−¥2.0bn2022-01-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥739m2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax−¥2.4bn2021-01-01 → 2021-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥2.1bn2021-01-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥700m2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)−¥2.0bn2022-01-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥801m2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥2.5bn2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥2.1bn2021-01-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥716m2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income−¥2.0bn2022-01-01 → 2022-09-30Cons.Profit loss IFRS
Net income−¥801m2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income−¥2.1bn2021-01-01 → 2021-09-30Cons.Profit loss IFRS
Net income−¥716m2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥4.3bnat 2022-09-30Cons.Assets IFRS
Total assets¥3.1bnat 2021-12-31Cons.Assets IFRS
Total assets¥3.7bnat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥1.1bnat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥556mat 2021-12-31Cons.Liabilities IFRS
Net assets / equity¥3.2bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥2.6bnat 2021-12-31Cons.Equity IFRS
Net assets / equity¥3.0bnat 2021-09-30Cons.Equity IFRS
Net assets / equity¥3.7bnat 2020-12-31dCons.Equity IFRS
Equity (owners)¥3.2bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥2.6bnat 2021-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥3.0bnat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥1.8bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥714mat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥1.2bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥3.0bnat 2020-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow−¥1.1bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow−¥2.5bn2021-01-01 → 2021-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow−¥2.0bn2021-01-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥418m2022-01-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥164m2021-01-01 → 2021-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥106m2021-01-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥2.6bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥361m2021-01-01 → 2021-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥372m2021-01-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-13.982022-01-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-4.952022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥-19.042021-01-01 → 2021-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-16.362021-01-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-5.462021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥-13.982022-01-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-4.952022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥-19.042021-01-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-16.362021-01-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-5.462021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio74.0%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio82.3%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio79.6%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 526
ItemContextValueUnit
Lease liabilities cl IFRSCurrentQuarterInstant48000000JPY
Other current liabilities cl IFRSPrior1YearInstant55000000JPY
Other current liabilities cl IFRSCurrentQuarterInstant51000000JPY
Total current liabilities IFRSPrior1YearInstant489000000JPY
Total current liabilities IFRSCurrentQuarterInstant1025000000JPY
Deferred tax liabilities IFRSPrior1YearInstant18000000JPY
Deferred tax liabilities IFRSCurrentQuarterInstant72000000JPY
Lease liabilities ncl IFRSPrior1YearInstant37000000JPY
Lease liabilities ncl IFRSCurrentQuarterInstant3000000JPY
Other non current liabilities ncl IFRSPrior1YearInstant10000000JPY
Other non current liabilities ncl IFRSCurrentQuarterInstant10000000JPY
Non current labilities IFRSPrior1YearInstant67000000JPY
Non current labilities IFRSCurrentQuarterInstant86000000JPY
Liabilities IFRSPrior1YearInstant556000000JPY
Liabilities IFRSCurrentQuarterInstant1111000000JPY
Share capital IFRSPrior1YearInstant2110000000JPY
Share capital IFRSCurrentQuarterInstant1431000000JPY
Capital surplus IFRSPrior1YearInstant5738000000JPY
Capital surplus IFRSCurrentQuarterInstant1501000000JPY
Retained earnings IFRSPrior1YearInstant-5204000000JPY
Retained earnings IFRSCurrentQuarterInstant275000000JPY
Treasury shares IFRSPrior1YearInstant-70000000JPY
Treasury shares IFRSCurrentQuarterInstant-70000000JPY
Other components of equity IFRSPrior1YearInstant13000000JPY
Other components of equity IFRSCurrentQuarterInstant30000000JPY
Equity IFRSPrior1YearInstant2587000000JPY
Equity IFRSCurrentQuarterInstant3169000000JPY
Liabilities and equity IFRSPrior1YearInstant3144000000JPY
Liabilities and equity IFRSCurrentQuarterInstant4281000000JPY
Revenue IFRSPrior1YTDDuration283000000JPY
Revenue IFRSCurrentYTDDuration485000000JPY
Cost of sales IFRSPrior1YTDDuration157000000JPY
Cost of sales IFRSCurrentYTDDuration132000000JPY
Gross profit IFRSPrior1YTDDuration125000000JPY
Gross profit IFRSCurrentYTDDuration352000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1YTDDuration822000000JPY
Research and development expenditure recognized as expense during period IFRSCurrentYTDDuration766000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration1367000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration1538000000JPY
Operating profit loss IFRSPrior1YTDDuration-2063000000JPY
Operating profit loss IFRSCurrentYTDDuration-1952000000JPY
Finance income IFRSPrior1YTDDuration0JPY
Finance income IFRSCurrentYTDDuration0JPY
Finance costs IFRSPrior1YTDDuration21000000JPY
Finance costs IFRSCurrentYTDDuration19000000JPY
Other income IFRSPrior1YTDDuration0JPY
Other income IFRSCurrentYTDDuration－JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration－JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration-1000000JPY
Profit loss before tax IFRSPrior1YTDDuration-2084000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2021-12-31pass rounding
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-01-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-01-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-01-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass